Integrative Cancer Therapies
Share

Integrative Cancer Therapies

2015 Impact Factor: 1.706
2015 Ranking: 172/213 in Oncology | 8/24 in Integrative & Complementary Medicine
2016 Release of Journal Citation Reports, Source: 2015 Web of Science Data

EDITOR
Keith I. Block, MD University of Illinois at Chicago, Institute for Integrative Cancer Care, USA


eISSN: 1552695X | ISSN: 15347354 | Current volume: 15 | Current issue: 4 Frequency: Bi-monthly
 As of January 2016, Integrative Cancer Therapies became a Gold open access publication publishing under a Creative Commons license and requiring no subscription to access.

ICT is the first journal to spearhead and focus on a new and growing movement in cancer treatment. The journal emphasizes scientific understanding of alternative medicine and traditional medicine therapies, and their responsible integration with conventional health care. Integrative care includes therapeutic interventions in diet, lifestyle, exercise, stress care, and nutritional supplements, as well as experimental vaccines, chrono-chemotherapy, and other advanced treatments. Contributors are leading oncologists, researchers, nurses, and health-care professionals.

The journal presents scientifically rigorous original research, case studies, current literature reviews, educational roundtables, and commentary on key topics such as:
  • Treatment strategies
  • Evaluations of current therapies
  • Models for integrating complementary and conventional treatment in clinical practice
  • Interventions from alternative and traditional medicine
  • Implementing quality-of-life assessment and counseling in the clinical setting
  • Cancer rehabilitation during and following cancer treatments
  • Potential interactions of cancer chemotherapy drugs with frequently used dietary supplements
  • Implementing integrative cancer care strategies into oncology practice
  • Relevant molecular mechanisms and biology behind integrative approaches
  • Impact of timing of chemotherapy administration on toxicity, response, and outcome

This journal is a member of the Committee on Publication Ethics (COPE)

 

Integrative Cancer Therapies focuses on a new and growing movement in cancer treatment. The journal emphasizes scientific understanding of alternative medicine and traditional medicine therapies, and their responsible integration with conventional health care. Integrative care includes therapeutic interventions in diet, lifestyle, exercise, stress care, and nutritional supplements, as well as experimental vaccines, chrono-chemotherapy, and other advanced treatments.

The journal presents scientifically rigorous original research, case studies, current literature reviews, educational roundtables, and commentary on key topics such as:

  • Treatment strategies
  • Evaluations of current therapies
  • Models for integrating complementary and conventional treatment in clinical practice
  • Interventions from alternative and traditional medicine
  • Implementing quality-of-life assessment and counseling in the clinical setting
  • Cancer rehabilitation during and following cancer treatments
  • Potential interactions of cancer chemotherapy drugs with frequently used dietary supplements
  • Implementing integrative cancer care strategies into oncology practice
  • Relevant molecular mechanisms and biology behind integrative approaches
  • Impact of timing of chemotherapy administration on toxicity
  • Response, and outcome by leading oncologists
  • Researchers, and health-care professionals

Three unique features of this publication are:

Integrative Grand Rounds: Insightful case studies from all viewpoints of case management plus commentary from the editors.

Point/Counterpoint: Lively discussions of controversial issues such as the interaction of antioxidants supplements and cancer chemotherapy or the effects of soy in treating breast cancer.

Patient's Perspective: Authoritative analysis of new treatments being actively used by patients.

This journal will be of particular interest to: medical, surgical, and radiation oncologists; clinical specialists frequently concerned with cancer such as urologists, gynecologists and women's health specialists; oncology and medical nurses; chiropractors; dietitians; pharmacists; and sophisticated lay people.

Associate Editors
Penny Block, PhD Block Center for Integrative Cancer Treatment
Elizabeth Krause, PharmD Chicago, Illinois, USA
Gail Mahady, PhD University of Illinois, USA
Peying Yang, PhD MD Anderson Cancer Center, University of Texas, USA
Managing Editor
Charlotte Gyllenhaal, PhD Institute for Integrative Cancer Care
International Editor
Jacob Shoham, MD, PhD Bar-Ilan University, Ramat-Gan, Israel
Assistant Editors
Advisory Board Members
Donald Abrams, MD University of California, San Francisco
Lorenzo Cohen, PhD M.D. Anderson Cancer Center
William Hrushesky, MD Rhythmalyltics, Inc, West Orange, NJ
Wayne Jonas, MD Uniformed Services University of the Health Sciences
Robert A. Nagourney, MD Rational Therapeutics Inc
Robert Newman, PhD Phoenix Biotechnology, San Antonio TX
Julia Rowland, PhD National Cancer Institute
Andrew Weill, MD University of Arizona, Tucson, AZ
Editorial Board
Lise Alschuler, ND, FABNO TAP Integrative, Green Bay, WI
Lynda G. Balneaves, PhD University of Manitoba, Winnipeg, Manitoba, Canada
Claudio Battaglini, PhD University of North Carolina, Chapel Hill, NC
Eran Ben-Arye, MD Lin Medical Center, and Technicon-Israel Institute of Technology, Haifa
Anupam Bishayee, Pharm D, PhD Larkin Health Sciences Institute, Miami, FL
Amit Budhraja, PhD St Jude's Children's Research Hospital, Memphis, USA
Terence Bugno, MD Northern Illinois Center for Cancer Care
Linda Carlson, PhD University of Calgary, Alberta, Canada
Alejandro Chaoul, PhD M.D. Anderson Cancer Center, Houston, TX, USA
Nicole Culos-Reed, PhD University of Calgary, Alberta, Canada
Yibin Feng, PhD University of Hong Kong, Pokfulam, Hong Kong
Moshe Frenkel, MD Meir Medical Center
Catherine Granger, PhD Royal Melbourne Hospital, Australia
Jim Grutsch, PhD James F Grutsch & Associates, Wilmette, IL
Judith Jacobson, MD Columbia University College of Physicians and Surgeons
Omer Kucuk, MD Emory University, Atlanta, GA
Elena Ladas, PhD Columbia University, New York, NY
Michael McCulloch, PhD Pine Street Foundation, San Francisco, CA
Dwight McKee, MD Mederi Foundation, Ashland, OR and Life Plus International, Batesville, AR
Mark Myers Block Center for Integrative Cancer Treatment
Byeongsang Oh, PhD University of Sydney, Sydney, Australia
Greg Plotnikoff, MD Minnesota Personalized Medicine, Minneapolis, MN
Mark Renneker, MD University of California, San Francisco, USA
Waheed Roomi, PhD Dr Rath Research Institute, Santa Clara, CA
Dugald Seeley, ND, MSc Ottawa Integrative Cancer Centre, Ottawa, Ontario
Victor S. Sierpina, MD University of Texas
Judith Smith, PharmD University of Texas Health Science Center at Houston
Leanna Standish, ND Bastyr University, Kenmore, WA
Stephen Sze, PhD University of Hong Kong, Pokfulam, Hong Kong
Chin-Kun Wang, PhD Chung Shan Medical University, Taichung
Wong-Bo Wang, PhD National Taiwan University, Taipei
Raimond Wong, MD Juravinski Cancer Center, Hamilton, Ontario
Hung-Rong Yen, MD, PhD China Medical University Hospital, Taiwan
Hwa Seung Yoo, PhD Daejon University, Daejon
Seong Woo Yoon, MD, PhD Kyung-Hee University, Gangdong
Editorial Consultants
Mark Blumenthal Executive Director, American Botanical Council
Michael Broffman, LAc Pine Street Clinic
Gar Hildenbrand Gerson Research Organization
Mark Myers, RD Block Center for Integrative Cancer Treatment
Donald R. Yance Jr., CN, MH, AHG Centre for Natural Healing
  • AgBiotech News and Information
  • AgBiotechNet
  • CAB Abstracts (Index Veterinarius, Veterinary Bulletin)
  • CAB Health
  • CABI: Abstracts on Hygiene and Communicable Diseases
  • CABI: CAB Abstracts
  • CABI: Forest Products Abstracts
  • CABI: Forestry Abstracts
  • CABI: Global Health
  • CABI: Nutrition Abstracts and Reviews Series A
  • CABI: Review of Aromatic and Medicinal Plants
  • CABI: Tropical Diseases Bulletin
  • CINAHL
  • Chemical Abstracts Service (CAS)
  • EMBASE
  • Elsevier BIOBASE/Current Awareness in Biological Sciences
  • Horticultural Science Abstracts
  • Index Medicus
  • InfoTrac (full text)
  • MEDLINE
  • Postharvest News and Information
  • ProQuest: International Pharmaceutical Abstracts
  • Rural Development Abstracts
  • Science Citation Index Expanded (Web of Science)
  • Scopus
  • Soybean Abstracts
  • Please review the full Integrative Cancer Therapies author guidelines before submitting a manuscript to the journal.

    ICT accepts Research Articles, Review Papers, Case Reports, Educational Articles, Letters to the Editor and Commentaries. Please review the author guidelines for more information on each paper type.

    This Journal is a member of the Committee on Publication Ethics.

    This Journal recommends that authors follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals formulated by the International Committee of Medical Journal Editors (ICMJE)

    Please read the guidelines below then visit the Journal’s submission site https://mc.manuscriptcentral.com/ict to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.

    There is no charge for submitting a paper to ICT. For each accepted manuscript, you will be charged a one-time Article Processing Charge (APC). This fee covers the cost of publication and ensures that your article will be freely open to all worldwide.
    Beginning January 1, 2017, the APC for Integrative Cancer Therapies will move to the price of $1350. This APC will apply to accepted articles with submission dates on or after January 1, 2017. Accepted articles with submission dates before January 1, 2017 will be assessed the introductory rate of $900.”

    Only manuscripts of sufficient quality that meet the aims and scope of Integrative Cancer Therapies will be reviewed.
    As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.

    Before publication SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. Integrative Cancer Therapies publishes manuscripts under Creative Commons licenses. The standard Integrative Cancer Therapies license is Creative Commons by Attribution Non-Commercial (CC BY-NC 3.0), which allows others to re-use the work without permission as long as the work is properly referenced and the use is non-commercial. For more information, you are advised to visit SAGE's OA licenses page.

    Any correspondence, queries or additional requests for information on the Manuscript Submission process should be sent to the Editorial Office as follows:


    Keith I. Block, M.D.,
    Editor-in-Chief, Integrative Cancer Therapies
    Block Center for Integrative Cancer Treatment
    5230 Old Orchard Road
    Skokie IL 60077
    Telephone: 847-492-3040

    For inquiries about the status of manuscripts after submission, please contact:

    Charlotte Gyllenhaal, Ph.D.,
    Managing Editor, Integrative Cancer Therapies
    Block Center for Integrative Cancer Treatment
    5230 Old Orchard Road
    Skokie IL 60077
    Telephone: 847-492-3040
    E-mail:
    cgyllenhaal@blockmedical.com

    Individual Subscription, Print Only


    Individual, Single Print Issue


    Institutional, Single Print Issue